Acadia Healthcare Company Inc vs S&P Global Inc — how do they compare? Acadia Healthcare Company Inc trades at $27.51 (market cap $2.79B), while S&P Global Inc trades at $420.2 (market cap $121.02B). The key difference: S&P Global Inc is far larger — about 43.4× Acadia Healthcare Company Inc's market cap, and S&P Global Inc pays a 0.95% dividend while Acadia Healthcare Company Inc pays none. Which is the better fit depends on your goals.
| ACHC | SPGI | |
|---|---|---|
Market Cap | $2.79B | $121.02B |
Sector | Health | Financials |
52-Week High | $35.61 | $528.04 |
52-Week Low | $11.68 | $370.42 |
Enterprise Value | $5.19B | $132.51B |
Dividend Yield | — | 0.95% |
Signals from Pluang's Aura AI — not financial advice
ACHC trades at $30.00, down 2.69% today, with a bearish technical signal and neutral oscillators. The company shows strong revenue growth to $3.31 billion in 2025 but faces profitability challenges with a net loss of $1.10 billion. Recent earnings beats and positive cash flow generation contrast with ongoing legal investigations and negative investor sentiment.
Analyst consensus remains bullish with a $36.00 price target (68% buy ratings), but significant risks include legal proceedings, negative margins, and technical bearishness. The stock offers potential upside if operational improvements materialize, though current headwinds warrant caution.
S&P Global (SPGI) trades at $411.14, down 1.83% on the day, amid a mixed technical and fundamental backdrop. The stock shows a bullish trend in moving averages but neutral oscillators, with key support at $405. Financially, the company reported strong revenue growth to $15.34B in 2025 and a net income margin of 30.54%, though it slightly missed Q4 2025 EPS estimates. Recent news highlights strategic collaborations, such as the expanded partnership with Microsoft, and index additions like Reddit to the S&P 500.
The outlook for SPGI remains positive, driven by robust fundamentals and a consensus analyst price target of $523.20, implying significant upside. Risks include rising debt levels and competitive pressures. Institutional sentiment is bullish, with 85.7% of analysts rating it a buy, though investors should monitor execution on growth initiatives and macroeconomic factors affecting credit markets.
Trailing returns across standard periods
Latest headlines on both assets
Acadia Healthcare is a leading provider of behavioral healthcare services across the US and Puerto Rico. It operates a network of psychiatric hospitals, residential treatment centers, and clinics for mental health and addiction recovery.
Read more on ACHC →S&P Global provides data and benchmarks to capital and commodity market participants. In 2021 and excluding IHS Markit, S&P Ratings was over 45% of the firm's revenue and over 55% of the firm's operating income. S&P Ratings is the largest credit rating agency in the world. The firm's other segments include Market Intelligence, Indices, and Platts. Market Intelligence provides desktop tools and other data solutions to investment banks, corporations, and other entities. Indices provides benchmarks for financial markets and is monetized through subscriptions, asset-based fees, and transaction-based royalties. Platts provides benchmarks to commodity markets, principally petroleum.
Read more on SPGI →